Therapeutic targeting of HER2–CB 2 R heteromers in HER2-positive breast cancer

  1. Blasco-Benito, S.
  2. Moreno, E.
  3. Seijo-Vila, M.
  4. Tundidor, I.
  5. Andradas, C.
  6. Caffarel, M.M.
  7. Caro-Villalobos, M.
  8. Urigüen, L.
  9. Diez-Alarcia, R.
  10. Moreno-Bueno, G.
  11. Hernández, L.
  12. Manso, L.
  13. Homar-Ruano, P.
  14. McCormick, P.J.
  15. Bibic, L.
  16. Bernadó-Morales, C.
  17. Arribas, J.
  18. Canals, M.
  19. Casadó, V.
  20. Canela, E.I.
  21. Guzmán, M.
  22. Pérez-Gómez, E.
  23. Sánchez, C.
Aldizkaria:
Proceedings of the National Academy of Sciences of the United States of America

ISSN: 1091-6490,  0027-8424

Argitalpen urtea: 2019

Alea: 116

Zenbakia: 9

Orrialdeak: 3863-3872

Mota: Artikulua

DOI: 10.1073/PNAS.1815034116 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus